Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting
about
Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot studyPresence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Management of invasive candidiasis in nonneutropenic ICU patients.Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyCandida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort StudiesEarly diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.(1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs)A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemiaProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.Invasive fungal infections in patients with cancer in the Intensive Care Unit.Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections.An Italian consensus for invasive candidiasis management (ITALIC).What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.IgG1 anti-cell wall and IgG2 anti-phosphopeptidomannan antibodies in the diagnosis of invasive candidiasis and heavy Candida colonization.β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.Candida biomarkers in patients with candidaemia and bacteraemia.β-D-glucan testing is important for diagnosis of invasive fungal infections.Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysisWhat has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study.T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.
P2860
Q33624899-09D6C3E5-9F63-4A67-8A62-67E0FC26EE85Q34374081-17CE89CF-56B9-4375-AFDD-7AB1D5B58C96Q34485719-763222A0-8FBB-4DAF-ACCA-787D1BCE5E17Q34505582-C88C19A4-75F6-4A74-8243-63B9A31225B7Q35122093-AA678306-5058-42AF-B4B0-6C9F02086CFEQ35331383-45201378-42AF-4CC6-A087-50954DAECA49Q35394057-322CC561-0D10-4147-9232-EB4CC3F4545DQ35530416-086DFEB1-D587-433C-ADF1-BAFA609635E2Q35681680-7646DD96-7920-4CF4-9E94-20F55DE53508Q35683091-F6FFF92E-F113-4D0F-B451-1DF83FB9AFFFQ35908296-10325D82-2998-454F-8EFE-DD3BE0409D3DQ36201457-E4844276-A8D5-41D6-B86A-AF797C259AE7Q36276211-4E1332E2-0E47-4686-B362-8D13CC20FB82Q36884375-DDC070A8-27FF-479C-A6D7-711BA1217806Q37089475-452717AF-9D1B-4D59-830C-E7C18E07CBD8Q37225323-EC56A73C-8E40-49BF-B748-3082255EA74EQ37373771-058F4609-0DE3-4B0B-8A44-92AECC56F9D0Q38067507-B1285E9B-6A94-47FE-808A-3E44136C4026Q38165883-DF9B85A6-8655-47B6-A69A-5D0110EE6BA9Q38203447-FF815F62-41F9-4CD0-975A-FBC21AF58BAFQ39355509-074A9447-7E7E-4AD2-B914-7CA65114B0E8Q39367519-6F0D55C2-63DF-4338-B544-939DA0BE2850Q40266645-57486CBE-00D1-43C3-ABB9-F11C70B5C6DAQ40948260-CDF86F84-5AEA-4222-B88A-E41591ED9723Q41031258-2D97E217-CD44-42FD-BC7B-70D30CB82FA0Q41114356-5449F71D-1D13-4046-9A0F-5632AFD57BD0Q41128217-EE941A61-5F82-4D64-9AEC-0DD8900BF6A9Q41299438-20D7169F-DAE3-45F7-8B7D-689AE7C26393Q41867984-C11B12F6-FFDA-4268-A47B-62A03B1205A3Q42129443-F128508A-E6BD-4552-B0E2-34046E74FBB7Q42258343-8E4EDE72-D2E9-4BC5-ACBB-5446DBE0513FQ42559150-5DA0EDD9-E1EC-413E-B6DC-2C6C8F77A329Q47749829-A583C9A3-2AC4-4CE3-A920-12477254A5C2Q51172824-51DE707A-D258-4883-88DB-7C0FA234B8BFQ55105395-4E5CEC83-2E3D-4881-98D0-A5AAA37ABB22Q55437393-0AF7EDD9-ABDA-4ED2-A497-A87FEE69CE75
P2860
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prospective survey of (1→3)-be ...... al intensive care unit setting
@ast
Prospective survey of (1→3)-be ...... al intensive care unit setting
@en
Prospective survey of
@nl
type
label
Prospective survey of (1→3)-be ...... al intensive care unit setting
@ast
Prospective survey of (1→3)-be ...... al intensive care unit setting
@en
Prospective survey of
@nl
prefLabel
Prospective survey of (1→3)-be ...... al intensive care unit setting
@ast
Prospective survey of (1→3)-be ...... al intensive care unit setting
@en
Prospective survey of
@nl
P2093
P2860
P356
P1476
Prospective survey of (1→3)-be ...... al intensive care unit setting
@en
P2093
Charles Sims
John F Mohr
Jose Rodriguez
Luis Ostrosky-Zeichner
Malcolm A Finkelman
Victor Paetznick
P2860
P356
10.1128/JCM.01240-10
P407
P50
P577
2010-11-03T00:00:00Z